Abstract
We report a 4-year-old girl with a complicated Enterococcus faecalis ventriculoperitoneal shunt infection who failed vancomycin therapy. We demonstrate linezolid's high CSF penetration and its CSF bacteriostatic activity against E. faecalis. Linezolid may be a good alternative for treatment of ventriculoperitoneal shunt infections in cases of vancomycin-resistant organisms or apparent treatment failures.
(c) 2007 S. Karger AG, Basel.
MeSH terms
-
Acetamides / pharmacology
-
Acetamides / therapeutic use*
-
Child
-
Enterococcus faecalis / drug effects*
-
Enterococcus faecalis / isolation & purification
-
Female
-
Gram-Positive Bacterial Infections / cerebrospinal fluid*
-
Gram-Positive Bacterial Infections / diagnosis
-
Gram-Positive Bacterial Infections / drug therapy
-
Humans
-
Linezolid
-
Oxazolidinones / pharmacology
-
Oxazolidinones / therapeutic use*
-
Ventriculoperitoneal Shunt / adverse effects*
Substances
-
Acetamides
-
Oxazolidinones
-
Linezolid